Close

ResMed (RMD) PT Raised to $250 at Wolfe Research

August 12, 2022 5:06 AM EDT
Get Alerts RMD Hot Sheet
Price: $222.71 -0.84%

Rating Summary:
    12 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 24 | New: 19
Join SI Premium – FREE
Wolfe Research analyst Mike Polark raised the price target on ResMed (NYSE: RMD) to $250.00 (from $230.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change